Moderna has said it plans to share access to its mRNA technology and set up clinical collaborations with Hong Kong universities. Photo: AFP
Moderna has said it plans to share access to its mRNA technology and set up clinical collaborations with Hong Kong universities. Photo: AFP

exclusive | Moderna seeking Hong Kong regulatory approval for Omicron-targeted Covid-19 booster vaccine

  • Patrick Bergstedt, US company’s senior vice-president of commercial vaccines, says discussions with city government at advanced stage, but no green light given yet
  • Company has plans to share access to its mRNA technology, set up clinical collaborations with Hong Kong universities

Moderna has said it plans to share access to its mRNA technology and set up clinical collaborations with Hong Kong universities. Photo: AFP
Moderna has said it plans to share access to its mRNA technology and set up clinical collaborations with Hong Kong universities. Photo: AFP
READ FULL ARTICLE